The nose can be the focus of treatment and prophylactic approaches against COVID-19
Infection with SARS-CoV-2 frequently commences in the nasal cavity, yet knowledge about this initial virus-host interaction is sparse. In this review, we update our current understanding of SARS-CoV-2 infection via the nasal epithelium and the associated local immune response. Furthermore, we present considerations to how this interaction may influence the clinical course of COVID-19 and the systemic immune response, and lastly touch upon the potential for intranasal vaccination, intranasal antiviral therapies and immunomodulatory approaches.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
---|---|
Enthalten in: |
Ugeskrift for laeger - 183(2021), 37 vom: 13. Sept. |
Sprache: |
Dänisch |
---|
Beteiligte Personen: |
Rusan, Maria [VerfasserIn] |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 08.10.2021 Date Revised 08.10.2021 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM331379376 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM331379376 | ||
003 | DE-627 | ||
005 | 20231225213330.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||dan c | ||
028 | 5 | 2 | |a pubmed24n1104.xml |
035 | |a (DE-627)NLM331379376 | ||
035 | |a (NLM)34596523 | ||
035 | |a (PII)V05210442 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a dan | ||
100 | 1 | |a Rusan, Maria |e verfasserin |4 aut | |
245 | 1 | 4 | |a The nose can be the focus of treatment and prophylactic approaches against COVID-19 |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.10.2021 | ||
500 | |a Date Revised 08.10.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Infection with SARS-CoV-2 frequently commences in the nasal cavity, yet knowledge about this initial virus-host interaction is sparse. In this review, we update our current understanding of SARS-CoV-2 infection via the nasal epithelium and the associated local immune response. Furthermore, we present considerations to how this interaction may influence the clinical course of COVID-19 and the systemic immune response, and lastly touch upon the potential for intranasal vaccination, intranasal antiviral therapies and immunomodulatory approaches | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
700 | 1 | |a Ovesen, Thomas Oliver Kamarauskas |e verfasserin |4 aut | |
700 | 1 | |a Fuursted, Kurt |e verfasserin |4 aut | |
700 | 1 | |a Ovesen, Therese |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ugeskrift for laeger |d 1945 |g 183(2021), 37 vom: 13. Sept. |w (DE-627)NLM000011185 |x 1603-6824 |7 nnns |
773 | 1 | 8 | |g volume:183 |g year:2021 |g number:37 |g day:13 |g month:09 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 183 |j 2021 |e 37 |b 13 |c 09 |